Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Psychedelic therapy in the treatment of addiction: the past, present and future.
Zafar R, Siegel M, Harding R, Barba T, Agnorelli C, Suseelan S, Roseman L, Wall M, Nutt DJ, Erritzoe D. Zafar R, et al. Among authors: barba t. Front Psychiatry. 2023 Jun 12;14:1183740. doi: 10.3389/fpsyt.2023.1183740. eCollection 2023. Front Psychiatry. 2023. PMID: 37377473 Free PMC article. Review.
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.
James E, Erritzoe D, Benway T, Joel Z, Timmermann C, Good M, Agnorelli C, Weiss BM, Barba T, Campbell G, Baker Jones M, Hughes C, Topping H, Boyce M, Routledge C. James E, et al. Among authors: barba t. Front Psychiatry. 2024 Jan 11;14:1305796. doi: 10.3389/fpsyt.2023.1305796. eCollection 2023. Front Psychiatry. 2024. PMID: 38274414 Free PMC article.
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
Barbut Siva J, Barba T, Kettner H, Kuc J, Nutt DJ, Carhart-Harris R, Erritzoe D. Barbut Siva J, et al. Among authors: barba t. J Psychopharmacol. 2024 Feb;38(2):145-155. doi: 10.1177/02698811231224217. Epub 2024 Jan 27. J Psychopharmacol. 2024. PMID: 38281075 Free PMC article.
Psychedelics and sexual functioning: a mixed-methods study.
Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B. Barba T, et al. Sci Rep. 2024 Feb 7;14(1):2181. doi: 10.1038/s41598-023-49817-4. Sci Rep. 2024. PMID: 38326446 Free PMC article.
Psychedelics and the 'inner healer': Myth or mechanism?
Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R. Peill J, et al. Among authors: barba t. J Psychopharmacol. 2024 May;38(5):417-424. doi: 10.1177/02698811241239206. Epub 2024 Apr 12. J Psychopharmacol. 2024. PMID: 38605658 Free PMC article. Clinical Trial.
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R. Erritzoe D, et al. Among authors: barba t. EClinicalMedicine. 2024 Sep 21;76:102799. doi: 10.1016/j.eclinm.2024.102799. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39764567 Free PMC article.
50 results